Lactiplantibacillus plantarum alleviates Parkinson’s disease progression by reducing enteroendocrine α-synuclein aggregation in a rotenone-induced mouse model

Parkinson's disease (PD) is a progressive neurodegenerative disorder driven by α-synuclein (α-syn) aggregation and accumulation. Recent evidence suggests that gut dysbiosis may trigger α-syn accumulation in the enteric nervous system, which spreads to the brain via the vagus nerve. Restoring the gut microbial balance through probiotic intervention offers a promising strategy to mitigate gut-origin pathology in PD. Lactiplantibacillus plantarum PS128 (PS128), a probiotic strain with neuroprotective properties, has shown neurotherapeutic benefits in PD models and patients; however, its mechanisms remain unclear. In a rotenone-induced PD mouse model, we found that PS128 supplementation significantly improved motor deficits and gastrointestinal dysfunction, reversed enteroendocrine cell (EEC) hyperplasia in the proximal colon (PC), and reduced α-syn accumulation in both intestinal and brain tissues. Notably, phosphorylated α-syn levels were significantly elevated in EECs, the myenteric plexus, and the substantia nigra, and these elevations were reversed by PS128. Furthermore, using real-time calcium imaging in a zebrafish model, we demonstrated that PS128 directly activates EECs. Transcriptomic profiling of the PC revealed calcium signaling and vitamin D metabolism as the major pathways modulated by PS128. Consistent with the transcriptomic findings, biochemical analyses demonstrated that PS128 increased serum calcium and 25-hydroxyvitamin D levels. Moreover, 16S rRNA sequencing and correlation analysis revealed that PS128 modulated gut microbiota composition in PD-like mice, with changes in specific taxa correlating with α-syn burden and calcium regulation. Taken together, our findings suggest that PS128 alleviates PD-like pathology through modulation of the gut-brain axis and provide mechanistic insights into the neuroprotective actions of probiotics.

Authors

Institutions

Publication Details

Journal
Biomedicine & Pharmacotherapy
Published
2026-11-12
DOI
https://doi.org/10.1016/j.biopha.2026.120007
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lactiplantibacillus plantarum alleviates Parkinson’s disease progression by reducing enteroendocrine α-synuclein aggregation in a rotenone-induced mouse model

Wei–Hsiang Chen, Tzu-Fun Fu, Ying-Chieh Tsai, Fu-Sheng Deng et al.
Biomedicine & Pharmacotherapy
Parkinson's Disease Mechanisms and Treatments
article

Lactiplantibacillus plantarum alleviates Parkinson’s disease progression by reducing enteroendocrine α-synuclein aggregation in a rotenone-induced mouse model

Wei–Hsiang Chen, Tzu-Fun Fu, Ying-Chieh Tsai, Fu-Sheng Deng, Ching-Ting Lin, Chien-Chen Wu, Yu-Fen Lin
article en

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder driven by α-synuclein (α-syn) aggregation and accumulation. Recent evidence suggests that gut dysbiosis may trigger α-syn accumulation in the enteric nervous system, which spreads to the brain via the vagus nerve. Restoring the gut microbial balance through probiotic intervention offers a promising strategy to mitigate gut-origin pathology in PD. Lactiplantibacillus plantarum PS128 (PS128), a probiotic strain with neuroprotective properties, has shown neurotherapeutic benefits in PD models and patients; however, its mechanisms remain unclear. In a rotenone-induced PD mouse model, we found that PS128 supplementation significantly improved motor deficits and gastrointestinal dysfunction, reversed enteroendocrine cell (EEC) hyperplasia in the proximal colon (PC), and reduced α-syn accumulation in both intestinal and brain tissues. Notably, phosphorylated α-syn levels were significantly elevated in EECs, the myenteric plexus, and the substantia nigra, and these elevations were reversed by PS128. Furthermore, using real-time calcium imaging in a zebrafish model, we demonstrated that PS128 directly activates EECs. Transcriptomic profiling of the PC revealed calcium signaling and vitamin D metabolism as the major pathways modulated by PS128. Consistent with the transcriptomic findings, biochemical analyses demonstrated that PS128 increased serum calcium and 25-hydroxyvitamin D levels. Moreover, 16S rRNA sequencing and correlation analysis revealed that PS128 modulated gut microbiota composition in PD-like mice, with changes in specific taxa correlating with α-syn burden and calcium regulation. Taken together, our findings suggest that PS128 alleviates PD-like pathology through modulation of the gut-brain axis and provide mechanistic insights into the neuroprotective actions of probiotics.

Biomedicine & PharmacotherapyVol. 205
National Yang Ming Chiao Tung University (TW), China Medical University (TW), National Cheng Kung University (TW)
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon